[Other] Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial

fahadfahad Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-01 18:13
Reward70points

Article Title: Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial


Authors: Prof Ziming Li, MD; ∙ Prof Jie Hu, MD PhD; ∙ Prof Jianhua Chen, MD;∙ Prof Yan Yu, MD; ∙ Prof Xiangjiao Meng, MD ;∙ Prof Xiaorong Dong, MD; ∙ et al.

Doi:
10.1016/S1470-2045(26)00090-2

Journal: The Lancet

Link to artcile: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00090-2
Reply

Use magic Donate Report

All Reply1 Show all posts
Florian1200 Post time 28 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Return to the list